The Prophylactic Effect of 5-Aminosalicylic Acid and Salazosulphapyridine on Degraded-Carrageenan-Induced Colitis in Guinea Pigs
Authors:
- 1 May 1984
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 19 (3) , 299-303
Abstract
Experimental colitis was induced in guinea pigs by administration of 5% degraded carrageenan for 5 days. The prophylactic effect of a slow-release preparation of 5-aminosalicylic acid (5-ASA; 13 mg/100 g per day) was compared with approximately equimolar amounts of salazosulfapyridine (SASP; 26 mg/100 g per day) and placebo. Treatment was started 2 days before initiation of carrageenan administration. The drugs were administered through a chronic gastric fistula. At the end of the study concentrations of 5-ASA and acetylated 5-ASA (Ac-5-ASA) in cecal contents and in plasma were determined. In the placebo group, all guinea pigs developed many small punctiform ulcerations in the cecum (median, 30/cm2). In the 5-ASA group no protective effect was demonstrated, since the number of ulcerations was 37/cm2. The difference is not statistically significant. However, the SASP group presented significantly fewer ulcerations (4/cm2). The concentrations of 5-ASA and/or its acetylated metabolite were several times higher in the cecum content and twice as high in plasma in the SASP group, indicating a difference in the absorption patterns of 5-ASA and the 2 drugs. These results and the etiological difference between the human ulcerative colitis and the carrageenan model may account for the lack of prophylactic effect of the slow-release 5-ASA in this experiment.Keywords
This publication has 13 references indexed in Scilit:
- 5-Aminosalicylic Acid in a Slow-Release Preparation: Bioavailability, Plasma Level, and Excretion in HumansGastroenterology, 1982
- Assay of 5-aminosalicylate and its acetylated metabolite in biological fluids by high-performance liquid chromatography on dynamically modified silicaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- The Effect of Metronidazole and Sulfasalazine on the Fecal Flora in Patients with Crohn's DiseaseScandinavian Journal of Gastroenterology, 1981
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- The comparative prophylactic effects of sulphasalazine, prednisolone and azathioprine in experimental colonic ulcerationJournal of Pharmacy and Pharmacology, 1980
- Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.Gut, 1980
- Stereomicroscopic Examination of Stained Rectal BiopsiesScandinavian Journal of Gastroenterology, 1978
- Protective effect of metronidazole in experimentalulcerative colitisGastroenterology, 1978
- PROTECTIVE EFFECT OF METRONIDAZOLE IN EXPERIMENTAL ULCERATIVE-COLITIS1978
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977